Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis
John Allotey(University of Birmingham), Shakila Thangaratinam(University of Liverpool), Tania Kew(University of Birmingham), Madelon van Wely(Amsterdam University Medical Centers), Van T. Tong(CDC Foundation), Adeolu Banjoko(University of Birmingham), Elena Kostova, Elena Stallings(Instituto Ramón y Cajal de Investigación Sanitaria), Asma Khalil(St George’s University Hospitals NHS Foundation Trust), Anna Thorson(World Health Organization), Simon Tiberi(Queen Mary University of London), Dyuti Coomar(University of Birmingham), Caron Rahn Kim(World Health Organization), Elisabeth van Leeuwen, Edna Kara(World Health Organization), Heidi Lawson(University of Birmingham), Mercedes Bonet(World Health Organization), Sascha Ellington(Centers for Disease Control and Prevention), Megan Littmoden(University of Birmingham), Kathryn Hughes Barry(University of Birmingham), Nathalie Broutet(World Health Organization), Jameela Sheikh(University of Liverpool), Dengyi Zhou(University of Birmingham), Sami L. Gottlieb(World Health Organization), Shruti Attarde(University of Birmingham), Dharshini Sambamoorthi(University of Birmingham), Heinke Kunst(Queen Mary University of London), Ramón Escuriet(FC Barcelona), Oluwadamilola Akande(University of Birmingham), Olufemi T. Oladapo(World Health Organization), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Javier Zamora(Instituto Cajal), Vanessa Brizuela(World Health Organization), Magnus Yap(University of Birmingham), Kehkashan Ansari(University of Birmingham)
Cited by 2,392
Related Papers
Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|2.4k
Meta-DiSc: a software for meta-analysis of test accuracy data
|BMC Medical Research Methodology|2006|1.9k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Estimates of the global burden of cervical cancer associated with HIV
|The Lancet Global Health|2020|912
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896